Showing results (371-380 of 383) with videos related to

Sort By:
Pageof 39
Kidney International|December 28, 2020
Supplemented ERA-EDTA Registry data evaluated the frequency of dialysis, kidney transplantation, and comprehensive conservative management for patients with kidney failure in EuropeVianda S Stel, Rianne W de Jong, Anneke Kramer, et al.
Clinical Journal of the American Society of Nephrology : CJASN|June 7, 2023
Clinical and Prognostic Factors in Patients with IgG4-Related Kidney DiseaseAnis Chaba, Arnaud Devresse, Vincent Audard, et al.
Blood Advances|May 7, 2025
Outcomes of Brexucabtagene Autoleucel in Relapsed/Refractory Acute Lymphoblastic Leukemia Patients with CNS InvolvementIbrahim N Muhsen, Gregory W Roloff, Rawan G Faramand, et al.
Scientific Reports|July 29, 2022
Detection of kinase domain mutations in BCR::ABL1 leukemia by ultra-deep sequencing of genomic DNARicardo Sánchez, Sara Dorado, Yanira Ruíz-Heredia, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 17, 2024
Outcomes After Brexucabtagene Autoleucel Administered as a Standard Therapy for Adults With Relapsed/Refractory B-Cell ALLGregory W Roloff, Ibrahim Aldoss, Noam E Kopmar, et al.
Blood|November 5, 2020
Chemotherapy or allogeneic transplantation in high-risk Philadelphia chromosome-negative adult lymphoblastic leukemiaJosep-Maria Ribera, Mireia Morgades, Juana Ciudad, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|September 24, 2025
Incidence and risk factors for portal vein complications after pediatric liver transplantation: A retrospective cohort analysis from the PORTAL registryBader A Alfares, Lydia Sieben, Weihao Li, et al.
Blood Advances|August 2, 2024
Impact of prior inotuzumab ozogamicin treatment on brexucabtagene autoleucel outcomes in adults with B-cell ALLIbrahim Aldoss, Gregory W Roloff, Rawan Faramand, et al.
Bone Marrow Transplantation|August 23, 2025
The impact of social determinants of health on outcomes of brexucabtagene autoleucel in adults with relapsed/refractory B-cell acute lymphoblastic leukemiaTimothy E O'Connor, Chenyu Lin, Gregory W Roloff, et al.
BMJ Open|July 27, 2023
Prevalence, management and efficacy of treatment in portal vein obstruction after paediatric liver transplantation: protocol of the retrospective international multicentre PORTAL registryBader A Alfares, Hubert P J van der Doef, Barbara E Wildhaber, et al.
Pageof 39